Trial Profile
Warning Time and Patient-Selected Goals: A Placebo Controlled Randomised Double-Blind Pilot Study of the Efficacy of Transdermal Oxybutynin for the Treatment of Urgency and Urge Incontinence
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 25 Mar 2019
Price :
$35
*
At a glance
- Drugs Oxybutynin (Primary)
- Indications Overactive bladder
- Focus Therapeutic Use
- Acronyms WTPCGTO
- 27 Jul 2011 Status changed from recruiting to completed as reported by ISRCTN: Current Controlled Trials.
- 12 Jul 2011 New source identified and integrated (European Clinical Trials Database).
- 12 Jul 2011 Trial phase changed from II to IV as reported by European Clinical Trials Database.